Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers
- PMID: 30755741
- DOI: 10.1038/s41586-019-0974-0
Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers
Abstract
The 'Competing interests' statement of this Article has been updated; please see the accompanying Amendment. The original Article has not been corrected online.
Erratum for
-
HER kinase inhibition in patients with HER2- and HER3-mutant cancers.Nature. 2018 Feb 8;554(7691):189-194. doi: 10.1038/nature25475. Epub 2018 Jan 31. Nature. 2018. PMID: 29420467 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
